Resources Contact Us Home
43 Kd protein vaccine and method for the production thereof

Image Number 3 for United States Patent #5543304.

A protein derivable from Actinobacillus pleuropneumoniae (APP) having a molecular size ranging between 43 Kd on SDS PAGE is described. The protein is soluble on sodium lauryl sarcosinate (SLS) and not heat modifiable. The protein can also be derived by recombinant methods. The protein in a vaccine provides immunity against multiple serotypes of APP.

  Recently Added Patents
Address generation unit for accessing a multi-dimensional data structure in a desired pattern
Media identification system with fingerprint database balanced according to search loads
Candle holder
Authenticating messages sent between a vehicle and a central facility
Piperazinyl methyl phenyl cyclohexane compound
Electric power supply system and electric power supply system for motor vehicle
Sperm factor sequences
  Randomly Featured Patents
Article exchange mechanism
Modular counter mounted fluid dispensing apparatus
Superhydrophobic poly(dimethylsiloxane) and methods for making the same
Light source device
Stereo system with piezo-electrical film speaker
Steroid intermediates for the formation of vitamin D.sub.3 analogues
Methods of managing timberland
Apparatus for forming piped openings in a garment
Biometrics with spatiospectral spoof detection